LEADING THE P&C INDUSTRY
Fueling the Mission to Protect Dreams and Restore Lives
By optimizing every step of the claims journey for the best possible outcomes.
1300+ Payers Trust Enlyte
Gain Control Over Your Outcomes, Don’t Just Manage the Claims
Claims stay on track when information, decisions, and actions move together. Only Enlyte connects the people, solutions, and data that shape claim outcomes so decisions happen earlier, performance stays visible, and you get measurable results.
A Smarter Approach to Auto Claims and Repair
Powered by industry-leading data and cloud-based technology, Mitchell, an Enlyte company, helps you simplify workflows, improve repair accuracy, source parts, and manage claims with confidence.
By directly connecting repairers with a network of suppliers, PartsTrader, an Enlyte company, improves transparency, reduces delays and controls costs.
Unique Perspectives from Established P&C Experts
Discover insights from our Enlyte experts, bringing you a unique perspective on the opportunities and challenges facing the industry today.
The Next Generation of Claim Handlers Is Forcing a Rethink of How Referral Management Gets Done
4 MIN READ
The claims industry is not only adopting new technology. It is also being reshaped by a new workforce.
State Regulatory Surge, Federal Shifts Reshaping Workers’ Comp
4 MIN READ
Explore how rising regulatory activity, AI oversight and evolving workplace policies are reshaping workers’ comp claims management. In this Claims Journal article, Enlyte experts break down the compliance, litigation and operational risks organizations should be watching closely.
Retail and Mail Order Prescriptions
3 MIN READ
Overall cost and utilization by claim were down in 2025 even with 6 of the top 10 therapeutic classes experiencing rising cost per script. Migraine medications rose by nearly 10%, representing the largest script cost gains driven in part by increases in brand Average Wholesale Price (AWP) including brand AWP for migraine medications increasing 2.4%. Utilization per claim also jumped in the migraine medication class (up 9.6%), while every other class within the top 10 (besides topicals, which rose 2.5%) experienced decreased utilization.
The Latest News from Enlyte
There’s always something happening at Enlyte. Keep up with all of the latest news and insights.
Read More